Cerebrospinal fluid (CSF) lactate for distinguishing acute bacterial meningitis from acute viral meningitis in adults
Date First Published:
April 24, 2018
Last Updated:
July 25, 2018
Report by:
Alexander Zozula, Resident Physician (Stanford University Department of Emergency Medicine)
Search checked by:
Christopher Stave, Stanford University Department of Emergency Medicine
Three-Part Question:
In [adults undergoing lumbar punctures for possible meningitis] what are [the sensitivity and specificity of CSF lactate] for [diagnosing acute community-acquired bacterial meningitis]?
Clinical Scenario:
You are evaluating a patient in the emergency department in whom you are considering the diagnosis of acute community-acquired bacterial meningitis. You perform a lumbar puncture and when ordering CSF studies wonder if sending a CSF lactate would help distinguish acute bacterial meningitis (ABM) from acute viral meningitis (AVM).
Search Strategy:
PubMed
((("bacteria"[mesh] OR "bacterial infections"[mesh]) AND ("meningitis"[mesh:noexp])) OR "meningitis, bacterial"[mesh] OR (mening*[tw] AND (bacteria*[tw] OR escherichia[tw] OR haemophilus[tw] OR listeria[tw] OR meningococc*[tw] OR neisseria[tw] OR pneumococc*[tw] OR streptococc*[tw]))
AND (“cerebrospinal fluid”[mesh] OR “cerebrospinal fluid”[subheading] OR “cerebrospinal fluid”[tw] OR “CSF”[tw]) AND (“lactates”[mesh] OR lacta*[tw] OR lacti*[tw]))
AND english[lang]
EMBASE
(((‘bacterium’/exp OR ‘bacterial infection’/exp) AND ‘meningitis’/exp) OR (mening*:ab,ti,kw AND (bacteria*:ab,ti,kw OR ‘escherichia’:ab,ti,kw OR ‘haemophilus’:ab,ti,kw OR listeria:ab,ti,kw OR meningococc*:ab,ti,kw OR ‘neisseria’:ab,ti,kw OR pneumococc*:ab,ti,kw OR streptococc*:ab,ti,kw)))
AND ((‘cerebrospinal fluid'/exp OR ‘cerebrospinal fluid’:ab,ti,kw OR ‘CSF’:ab,ti,kw) AND (‘lactic acid'/exp OR lact*:ab,ti,kw))
AND [english]/lim
((("bacteria"[mesh] OR "bacterial infections"[mesh]) AND ("meningitis"[mesh:noexp])) OR "meningitis, bacterial"[mesh] OR (mening*[tw] AND (bacteria*[tw] OR escherichia[tw] OR haemophilus[tw] OR listeria[tw] OR meningococc*[tw] OR neisseria[tw] OR pneumococc*[tw] OR streptococc*[tw]))
AND (“cerebrospinal fluid”[mesh] OR “cerebrospinal fluid”[subheading] OR “cerebrospinal fluid”[tw] OR “CSF”[tw]) AND (“lactates”[mesh] OR lacta*[tw] OR lacti*[tw]))
AND english[lang]
EMBASE
(((‘bacterium’/exp OR ‘bacterial infection’/exp) AND ‘meningitis’/exp) OR (mening*:ab,ti,kw AND (bacteria*:ab,ti,kw OR ‘escherichia’:ab,ti,kw OR ‘haemophilus’:ab,ti,kw OR listeria:ab,ti,kw OR meningococc*:ab,ti,kw OR ‘neisseria’:ab,ti,kw OR pneumococc*:ab,ti,kw OR streptococc*:ab,ti,kw)))
AND ((‘cerebrospinal fluid'/exp OR ‘cerebrospinal fluid’:ab,ti,kw OR ‘CSF’:ab,ti,kw) AND (‘lactic acid'/exp OR lact*:ab,ti,kw))
AND [english]/lim
Outcome:
PubMed -- 506 results
EMBASE -- 643 results
Total -- 742 unique results
106 full text articles were reviewed after screening titles/abstracts from which 33 original articles and two systematic reviews were ultimately selected for inclusion. One of the 33 articles (Schwarz et al.) was initially screened out but ultimately included after reviewing the two systematic reviews and the full text of the article. For completeness, the original articles included in the two systematic reviews are listed below as there appear to be several minor discrepancies in the data abstracted in the systematic reviews.
EMBASE -- 643 results
Total -- 742 unique results
106 full text articles were reviewed after screening titles/abstracts from which 33 original articles and two systematic reviews were ultimately selected for inclusion. One of the 33 articles (Schwarz et al.) was initially screened out but ultimately included after reviewing the two systematic reviews and the full text of the article. For completeness, the original articles included in the two systematic reviews are listed below as there appear to be several minor discrepancies in the data abstracted in the systematic reviews.
Relevant Paper(s):
Study Title | Patient Group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
CSF lactate level: a useful diagnostic tool to differentiate acute bacterial and viral meningitis. Abro et al. 2009 UAE | Single hospital Mean 34±12y, 84% male n=53 ABM, n=42 AVM |
Cohort Lactate cutoff 3.8mM |
Sensitivity | 98.10% | Excluded ABM without organism identified Significant overlap in patients with Abro et al. 2008 |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | 0.019 | ||||
Cerebrospinal fluid analysis: acute bacterial versus viral meningitis Abro et al. 2008 UAE | Single hospital Mean 34±12y, 87% male n=86 ABM, n=48 AVM |
Cohort Lactate cutoff 3.8mM |
Sensitivity | 98.8% (?erroneously reported as 98.3% by authors) | Significant overlap in patients with Abro et al. 2009 |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | 0.012 | ||||
Cerebrospinal fluid lactate in the diagnosis of meningitis. Diagnostic value compared to standard biochemical methods. Berg et al. 1982 Sweden | Multicenter Mean 30 vs. 21y ABM vs. AVM n=18 ABM, n=121 AVM |
Cohort Lactate cutoff 3.0mM |
Sensitivity | 88.90% | Excluded ABM without organism identified |
Specificity | 92.60% | ||||
LR+ | 12 | ||||
LR- | 0.12 | ||||
Comparison between cerebrospinal fluid concentrations of glucose, total protein, chloride, lactate, and total amino acids for the differential diagnosis of patients with meningitis. Briem et al. 1983 Sweden | Single hospital Mean 44 vs. 29y ABM vs. AVM, 52% male n=45 ABM, n=102 AVM |
Cohort Lactate cutoff 3.5mM |
Sensitivity | 100% | Excluded ABM without organism identified |
Specificity | 96.10% | ||||
LR+ | 25.5 | ||||
LR- | |||||
Measurement of lactic acid in cerebrospinal fluid of patients with infections of the central nervous system. Brook et al. 1978 USA | Single hospital 54% adults n=25 ABM, n=26 AVM |
Cohort Lactate cutoff 3.9mM using chromatographic method |
Sensitivity | 100% | Excluded ABM without organism identified |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | |||||
Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis/encephalitis in adults: a Danish prospective observational cohort Buch et al. 2018 Denmark | Multicenter Median 64 vs. 41y ABM vs. AVM, 51% male n=51 ABM, n=125 AVM |
Cohort Lactate cutoff 3.5/4.5mM using Radiometer analyzer |
Sensitivity | 96.1%/92.2% | |
Specificity | 84.8%/94.4% | ||||
LR+ | 6.32/16.5 | ||||
LR- | 0.046/0.083 | ||||
The clinical diagnostic significance of cerebrospinal fluid d-lactate for bacterial meningitis Chen et al. 2012 China | Single hospital Mean 43±15 vs. 32±17y, 45% vs. 67% male ABM vs. AVM n=21 ABM, n=30 AVM |
Cohort Lactate cutoff 3.3mM |
Sensitivity | 71.40% | Included patients pretreated with antibiotics/steroids |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | 0.286 | ||||
Cerebrospinal fluid lactate and the diagnosis of meningitis. Curtis et al. 1981 UK | Two hospitals Unknown demographics n=10 ABM, n=12 AVM |
Cohort Lactate cutoff 2.8mM |
Sensitivity | 100% | Excluded ABM without organism identified |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | |||||
Lactic-acid concentration in cerebrospinal fluid and differential diagnosis of meningitis. D'Souza et al. 1978 UK | Two hospitals Unknown demographics n=5 ABM, n=26 AVM |
Cohort Lactate cutoff 4.3mM |
Sensitivity | 100% | Unclear definition of ABM |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | |||||
Cerebrospinal fluid lactic acid: a valuable aid in the of diagnosis septic meningitis. Ellis and Oei 1979 USA | Single hospital Unknown demographics n=10 ABM, n=12 "CNS inflammation" including AVM |
Cohort Lactate cutoff 5.0mM |
Sensitivity | 100% | Excluded ABM without organism identified "CNS inflammation" group included not only AVM but also leukemia, ICH, MS, and "hypoxic seizures" |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | |||||
Gas liquid chromatography in the rapid diagnosis of meningitis. Ferguson and Tearle 1977 UK | Single hospital Unknown demographics n=8 ABM, n=15 AVM |
Cohort Lactate cutoff 5.6mM using chromatographic method |
Sensitivity | 100% | Unclear definition of ABM Included patients pretreated with antibiotics |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | |||||
Rapid diagnosis of meningitis with use of selected clinical data and gas-liquid chromatographic determination of lactate concentration in cerebrospinal fluid. Gastrin et al. 1979 Sweden | Single hospital Median 33 vs. 54 vs. 24y ABM vs. presumed ABM vs. AVM n=38 ABM, n=5 presumed ABM, n=17 AVM |
Cohort Lactate cutoff 3.5mM using chromatographic method |
Sensitivity | 96% | Included patients pretreated with antibiotics |
Specificity | 82.40% | ||||
LR+ | 5.4 | ||||
LR- | 0.056 | ||||
Cerebrospinal fluid lactate in 78 cases of adult meningitis. Genton and Berger 1990 Switzerland | Single hospital Median 35/33y M/F, 46% male n=25 ABM, n=28 AVM |
Cohort Lactate cutoff 4.2 using Hoffman-La Roche analyzer |
Sensitivity | 96% | Included patients pretreated with antibiotics Excluded ABM without organism identified |
Specificity | 96.4% (erroneously reported as 100% by authors) | ||||
LR+ | 26.9 | ||||
LR- | 0.041 | ||||
CSF lactate for accurate diagnosis of community-acquired bacterial meningitis Giulieri et al. 2015 Switzerland | Multicenter Median 53 vs. 35y, 50% vs. 56% male ABM vs. AVM n=18 ABM, n=27 AVM |
Cohort Lactate cutoff 3.5mM |
Sensitivity | 100% | Excluded ABM without organism identified Excluded AVM without organism identified |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | |||||
The use of cerebrospinal fluid lactate determination in the diagnosis of meningitis. Gould et al. 1980 UK | Single hospital Unknown demographics n=6 ABM, n=26 AVM |
Cohort Lactate cutoff 3.4mM using chromatographic method |
Sensitivity | 83.30% | ABM group included TB meningitis |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | 0.167 | ||||
Lactic acid in cerebrospinal fluid: evaluation and application of an automated enzymatic assay. Herold et al. 1981 USA | Single hospital Unknown demographics n=9 ABM, n=2 AVM |
Cohort Lactate cutoff 9mM |
Sensitivity | 100% | Unclear definition of ABM n=2 AVM makes the specificity extraordinarily fragile |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | |||||
Use of cerebrospinal fluid lactate levels in the diagnosis of bacterial meningitis. Hurd et al. 1978 USA | Single affiliated adult/children hospital 77% adult n=11 ABM, n=80 comparator group including AVM |
Cohort Lactate cutoff 3.4mM using chromatographic method |
Sensitivity | 100% | Excluded ABM without organism identified Comparator group included not only AVM but also ICH, cancer, and post-neurosurgical patients |
Specificity | 97.50% | ||||
LR+ | 40 | ||||
LR- | |||||
CSF lactate in diseases of the CNS. Jordan et al. 1983 USA | Single hospital Unknown demographics n=7 ABM, n=3 AVM |
Cohort Lactate cutoff 3.0mM |
Sensitivity | 100% | Excluded ABM without organism identified n=3 AVM makes the specificity extraordinarily fragile |
Specificity | 66.70% | ||||
LR+ | 3 | ||||
LR- | |||||
New and old diagnostic markers of meningitis in cerebrospinal fluid (CSF). Kleine et al. 2003 Germany | Single hospital Mean 49.5 vs. 43.1y, 58% vs. 54% male ABM vs. AVM n=40 ABM, n=46 AVM |
Cohort Lactate cutoff 3.5mM |
Sensitivity | 100% | Excluded ABM without organism identified |
Specificity | 100% (?erroneously reported as 99.6% by authors) | ||||
LR+ | Infinity | ||||
LR- | |||||
Cerebrospinal fluid lactic acid in diagnosis of meningitis. Komorowski et al. 1978 USA | Single hospital Unknown demographics n=21 "CNS infections", n=3 AVM |
Cohort Lactate cutoff 3.4mM using chromatographic method |
Sensitivity | 100% | Unclear definition of ABM "CNS infections" included not only ABM but also fungal meningitis and CNS syphilis n=3 AVM makes the specificity extraordinarily fragile |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | |||||
Comparison of cerebrospinal fluid C-reactive protein and lactate for diagnosis of meningitis. Komorowski et al. 1986 USA | Single hospital Unknown demographics n=28 ABM, n=5 AVM |
Cohort Lactate cutoff 3.0mM |
Sensitivity | 100% | Excluded ABM without organism identified |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | |||||
Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults Lagi et al. 2016 Italy | Single ED 51% male n=24 ABM, n=641 comparator group including AVM |
Cohort Lactate cutoff 3.9mM |
Sensitivity | 100% | Data not published -- personal communication from author Excluded ABM without organism identified and cases with organisms thought to represent contamination Comparator group included not only AVM but all patients undergoing lumbar puncture to evaluate for meningitis and ultimately deemed to not have ABM |
Specificity | 97% | ||||
LR+ | 33.7 | ||||
LR- | |||||
Chemical analyses for early differential diagnosis between bacterial and viral meningitis. Landaas and Von Der Lippe 1985 Norway | Single hospital 47% vs. 52% male ABM vs. AVM n=19 ABM, n=24 AVM |
Cohort Lactate cutoff 6.0mM |
Sensitivity | 84.20% | Included patients pretreated with antibiotics Excluded ABM without organism identified |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | 0.158 | ||||
Evaluation of cerebrospinal fluid lactic acid levels as an aid in differential diagnosis of bacterial and viral meningitis in adults. Lannigan et al. 1980 Canada | Single hospital 58% male n=14 ABM, n=14 AVM |
Cohort Lactate cutoff 3.9mM |
Sensitivity | 92.90% | Excluded ABM without organism identified |
Specificity | 78.60% | ||||
LR+ | 4.33 | ||||
LR- | 0.091 | ||||
Lactic-acid concentration in cerebrospinal fluid and differential diagnosis of meningitis. Lauwers 1978 Belgium | Single hospital Unknown demographics n=35 ABM, n=20 AVM |
Cohort Lactate cutoff 3.9mM using chromatographic method |
Sensitivity | 100% | Excluded ABM without organism identified |
Specificity | 100% | ||||
LR+ | Infinity | ||||
LR- | |||||
Value of CSF lactate in the differential diagnosis between bacterial meningitis and other diseases with meningeal involvement. Lester et al. 1985 Denmark | Multicenter Unknown demographics n=16 ABM, n=15 AVM |
Cohort Lactate cutoff 3.5mM |
Sensitivity | 93.80% | Included patients pretreated with antibiotics |
Specificity | 86.70% | ||||
LR+ | 7.03 | ||||
LR- | 0.072 | ||||
Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection. Lindquist et al. 1988 Sweden | Multicenter Unknown demographics n=63 ABM, n=616 comparator group including AVM |
Cohort Lactate cutoff 3.5mM |
Sensitivity | 88.90% | ABM group included TB meningitis Comparator group included not only AVM but also "unclassified meningitis", other infectious CNS conditions, seizures, and strokes |
Specificity | 96.40% | ||||
LR+ | 24.9 | ||||
LR- | 0.115 | ||||
How useful is cerebrospinal fluid lactate estimation in differential diagnosis of meningitis? Mandal et al. 1983 UK | Single hospital Unknown demographics n=20 ABM, n=59 AVM |
Cohort Lactate cutoff 4.3mM |
Sensitivity | 100% | |
Specificity | 98.30% | ||||
LR+ | 59 | ||||
LR- | |||||
Handheld Point-of-Care Cerebrospinal Fluid Lactate Testing Predicts Bacterial Meningitis in Uganda Patterson et al. 2013 Uganda | Single hospital Mean 31±13y, 50% male, 81% HIV+ n=17 ABM, n=128 comparator group including AVM |
Cohort Lactate cutoff 7.7mM using Accutrend POC analyzer |
Sensitivity | 88.20% | Comparator group included not only AVM but also fungal and TB meningitis |
Specificity | 89.80% | ||||
LR+ | 8.69 | ||||
LR- | 0.131 | ||||
The differential diagnosis of bacterial and aseptic meningitis using cerebrospinal fluid laboratory tests. Ponka et al. 1983 Finland | Single hospital Unknown demographics n=11 ABM, n=27 AVM |
Cohort Lactate cutoff 3.0mM |
Sensitivity | 90.90% | Excluded ABM without organism identified |
Specificity | 96.30% | ||||
LR+ | 24.5 | ||||
LR- | 0.094 | ||||
Serum procalcitonin levels in bacterial and abacterial meningitis. Schwarz et al. 2000 Germany | Single hospital Mean 52y, 43% male n=16 ABM, n=14 AVM |
Cohort Lactate cutoff 2.1mM using unknown method |
Sensitivity | 93.80% | No mention of lactate assay method (main focus of study was procalcitonin) Used lower cutoff of 2.1mM based on normal reference range |
Specificity | 42.90% | ||||
LR+ | 1.64 | ||||
LR- | 0.146 | ||||
Meningitis in adult patients with a negative direct cerebrospinal fluid examination: value of cytochemical markers for differential diagnosis Viallon et al. 2011 France | Single ED Mean 55±20 vs. 35±18y, 48% vs. 53% male ABM vs. AVM n=35 ABM, n=218 AVM |
Cohort Lactate cutoff 3.8mM using i-STAT POC analyzer |
Sensitivity | 94.30% | Excluded ABM with initially positive gram stain/antigen detection Excluded ABM with concurrent alternative infection (e.g. pneumonia) Excluded culture-negative ABM |
Specificity | 96.80% | ||||
LR+ | 29.4 | ||||
LR- | 0.059 | ||||
Quantitation of cerebrospinal fluid lactic acid in infectious and non-infectious neurological diseases de Almeida et al. 2009 Brazil | Single hospital Mean 21±20y, 53% male n=20 ABM, n=41 AVM |
Cohort Lactate cutoff 3.5mM using Date Behring analyzer |
Sensitivity | 80% | |
Specificity | 97.60% | ||||
LR+ | 32.8 | ||||
LR- | 0.205 | ||||
Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis Huy et al. 2010 | 25 studies included (both adults and children) n=783 ABM, n=909 AVM |
Systematic review and meta-analysis | AUC CSF lactate | 0.984 | Excluded non-English studies No gray literature Excluded studies with n<8 for either ABM or AVM Excluded studies with comparator groups including but not exclusively comprised of AVM |
AUC CSF WBC | 0.948 | ||||
AUC CSF glucose | 0.881 | ||||
AUC CSF/plasma glucose | 0.952 | ||||
AUC CSF protein | 0.862 | ||||
Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: A meta-analysis Sakushima et al. 2011 | 33 studies included (both adults and children) n=934 ABM, n=951 AVM |
Systematic review and meta-analysis | Sensitivity | 93% | Excluded non-English studies No gray literature Excluded studies with comparator groups including but not exclusively comprised of AVM |
Specificity | 96% | ||||
LR+ | 22.9 | ||||
LR- | 0.07 |
Author Commentary:
Distinguishing acute bacterial meningitis from acute viral meningitis can be challenging. While a strategy of treating all possible cases of ABM with broad spectrum antibiotics until CSF cultures result is commonly employed, this strategy may lead to antibiotic resistance and unnecessary hospitalization. A combination of CSF white blood cell count/differential, CSF glucose, and CSF protein is commonly used to distinguish ABM from AVM. Unfortunately these tests all suffer from suboptimal sensitivity and specificity. The ideal test would be maximally sensitive and specific, rapidly available, and cheap. Despite not being commonly used, CSF lactate has been widely studied and appears to satisfy all three domains. The median cutoff used in the included studies was 3.5mM (~31mg/dL), with the majority of studies using enzymatic assays. As with most CSF tests including the gold-standard culture, CSF lactate's utility is somewhat limited in patients pretreated with antibiotics. In such cases, a lower cutoff should be used to maintain sufficient sensitivity.
Bottom Line:
CSF lactate at a cutoff of 3.5mM appears to be both a sensitive and specific test for distinguishing acute bacterial meningitis from acute viral meningitis. With over 30 studies supporting its use over the past 40 years, it appears ready for routine use.
References:
- Abro et al.. CSF lactate level: a useful diagnostic tool to differentiate acute bacterial and viral meningitis.
- Abro et al.. Cerebrospinal fluid analysis: acute bacterial versus viral meningitis
- Berg et al.. Cerebrospinal fluid lactate in the diagnosis of meningitis. Diagnostic value compared to standard biochemical methods.
- Briem et al.. Comparison between cerebrospinal fluid concentrations of glucose, total protein, chloride, lactate, and total amino acids for the differential diagnosis of patients with meningitis.
- Brook et al.. Measurement of lactic acid in cerebrospinal fluid of patients with infections of the central nervous system.
- Buch et al.. Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis/encephalitis in adults: a Danish prospective observational cohort
- Chen et al.. The clinical diagnostic significance of cerebrospinal fluid d-lactate for bacterial meningitis
- Curtis et al.. Cerebrospinal fluid lactate and the diagnosis of meningitis.
- D'Souza et al.. Lactic-acid concentration in cerebrospinal fluid and differential diagnosis of meningitis.
- Ellis and Oei. Cerebrospinal fluid lactic acid: a valuable aid in the of diagnosis septic meningitis.
- Ferguson and Tearle. Gas liquid chromatography in the rapid diagnosis of meningitis.
- Gastrin et al.. Rapid diagnosis of meningitis with use of selected clinical data and gas-liquid chromatographic determination of lactate concentration in cerebrospinal fluid.
- Genton and Berger. Cerebrospinal fluid lactate in 78 cases of adult meningitis.
- Giulieri et al.. CSF lactate for accurate diagnosis of community-acquired bacterial meningitis
- Gould et al.. The use of cerebrospinal fluid lactate determination in the diagnosis of meningitis.
- Herold et al.. Lactic acid in cerebrospinal fluid: evaluation and application of an automated enzymatic assay.
- Hurd et al.. Use of cerebrospinal fluid lactate levels in the diagnosis of bacterial meningitis.
- Jordan et al.. CSF lactate in diseases of the CNS.
- Kleine et al.. New and old diagnostic markers of meningitis in cerebrospinal fluid (CSF).
- Komorowski et al.. Cerebrospinal fluid lactic acid in diagnosis of meningitis.
- Komorowski et al.. Comparison of cerebrospinal fluid C-reactive protein and lactate for diagnosis of meningitis.
- Lagi et al.. Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults
- Landaas and Von Der Lippe. Chemical analyses for early differential diagnosis between bacterial and viral meningitis.
- Lannigan et al.. Evaluation of cerebrospinal fluid lactic acid levels as an aid in differential diagnosis of bacterial and viral meningitis in adults.
- Lauwers. Lactic-acid concentration in cerebrospinal fluid and differential diagnosis of meningitis.
- Lester et al.. Value of CSF lactate in the differential diagnosis between bacterial meningitis and other diseases with meningeal involvement.
- Lindquist et al.. Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection.
- Mandal et al.. How useful is cerebrospinal fluid lactate estimation in differential diagnosis of meningitis?
- Patterson et al.. Handheld Point-of-Care Cerebrospinal Fluid Lactate Testing Predicts Bacterial Meningitis in Uganda
- Ponka et al.. The differential diagnosis of bacterial and aseptic meningitis using cerebrospinal fluid laboratory tests.
- Schwarz et al.. Serum procalcitonin levels in bacterial and abacterial meningitis.
- Viallon et al.. Meningitis in adult patients with a negative direct cerebrospinal fluid examination: value of cytochemical markers for differential diagnosis
- de Almeida et al.. Quantitation of cerebrospinal fluid lactic acid in infectious and non-infectious neurological diseases
- Huy et al.. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis
- Sakushima et al.. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: A meta-analysis